Prime Medicine, Inc.

NASDAQ:PRME

Biotechnology

Healthcare
$3.84 -1.11%

-$0.04 today

Market cap
$698.58M
Beta
2.31
P/E (TTM)
-2.8
EPS (TTM)
-$1.12
52W Low $1.77High $6.94

Volume 3.99M

Average 2.47M

Price history

Prime Medicine, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+4.07%

Period high

$5.36

Period low

$2.70

Latest

$3.84

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13D/ANov 13, 2026Nov 13, 2026
SC 13GNov 13, 2026Nov 13, 2026
10-QNov 12, 2026Nov 12, 2026
8-KNov 12, 2026Nov 12, 2026
8-KNov 12, 2026Nov 12, 2026
424B5Nov 12, 2026Nov 12, 2026
424B5Nov 10, 2026Nov 10, 2026
8-KNov 10, 2026Nov 10, 2026
8-KAug 6, 2026Aug 6, 2026
10-QAug 6, 2026Aug 6, 2026
8-KJul 8, 2026Jul 8, 2026
4Jun 8, 2026Jun 8, 2026
4Jun 8, 2026Jun 8, 2026
4Jun 8, 2026Jun 8, 2026
4Jun 8, 2026Jun 8, 2026

Competitors

Who does Prime Medicine, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about PRME's filings, answered from its disclosures.

What is the latest PRME filing?

The latest filing shown is SC 13D/A dated Nov 13, 2026.

How many recent filings does PRME have?

Intrinsic Alpha currently shows 20 recent filings for PRME.